INmune Bio INMB reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
INmune Bio beat estimated earnings by 24.0%, reporting an EPS of $-0.38 versus an estimate of $-0.5.
Revenue was up $16 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.25 which was followed by a 3.87% increase in the share price the next day.
To track all earnings releases for INmune Bio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.